Dabur India Ltd. Share Price

Dabur India – Technical Analysis, Support and Resistance

The stock

India Makhana Production & Export Outlook

India exported over 7,000 metric tonnes of makhana and value-added makhana products to more than 20 international markets in FY26, including the United States, the Middle East, and Africa, according to the Ministry of Commerce. As the world’s largest producer, India’s cultivation is primarily concentrated in Bihar, West Bengal, and Assam, with Bihar alone accounting for nearly 85% of total domestic production. The GI-tagged Mithila Makhana is gaining widespread international recognition for its rich nutritional profile and culinary versatility. Supported by rising global health consciousness, innovative startups creating ready-to-eat consumer products, and active participation from Farmer-Producer Organisations (FPOs), the sector is rapidly transitioning from a regional specialty into a global superfood category. To formalize trade and accelerate export growth, the Government of India implemented a dedicated Harmonised System (HS) code for makhana in July 2025, enabling precise tracking in international trade databases. This was followed by the launch of the National Makhana Board in Bihar on September 15, 2025, alongside the approval of a ₹476.03 crore ($53.87 million) Central Sector Scheme running through 2030–31, featuring targeted allocations of ₹30 crore ($3.39 million) for FY26 and ₹90 crore ($9.47 million) for FY27. Designed to modernize harvesting and post-harvest infrastructure, the scheme focuses on high-quality seed distribution, R&D, branding, export promotion, and quality assurance—enhancing Bihar’s agricultural incomes while expanding the global footprint of GI-tagged Mithila Makhana.

Academic & Corporate R&D Drives 70% of Ayush Patents

Ayush-related innovation and intellectual property activity in India recorded substantial growth between FY15 and FY26, with 4,077 patent applications filed and 711 patents granted, according to the Status Report on Ayush Related Inventions in India (2014–2026). Published by the Office of the Controller General of Patents, Designs & Trademarks (CGPDTM) under DPIIT and released during the 11th Ayurveda Day celebrations, the report highlights an 836.5% surge in annual filings—climbing from 63 in FY15 to 590 in FY26, after peaking at 606 in FY23. Over the same period, annual patent grants expanded from just three in FY16 to a high of 204 in FY24, reflecting an elevated focus on research rigor and formal intellectual property protection across traditional medicine systems. The post-COVID-19 era served as a primary catalyst for innovation, accounting for 2,854 applications (70% of total filings) and 657 grants (92.4% of total approvals) between FY21 and FY26. Individual inventors ("natural persons") led patenting activity with 2,113 filings (51.9%) and 398 grants, followed by academic institutions with 995 applications and corporate entities with 700 filings and 176 grants, alongside active contributions from startups and small enterprises. MoS (IC) for Ayush Prataprao Jadhav emphasized that this momentum underscores the nation's resolve to safeguard traditional knowledge, while Ayush Secretary Rajesh Kotecha noted that expanding partnerships across academia, startups, and industry will accelerate the commercial translation of therapeutic research into global healthcare solutions.

Colgate-Palmolive India Q2FY27 revenue up 12%, PAT rises 4%

Bajaj Consumer Care reports 66% rise in Q2 net profit

Bajaj Consumer Care has reported its results for the second quarter ended September 30, 2026 (Q2FY27). The company has reported a 64.87% rise in its standalone net profit at Rs 70.53 crore for the quarter ended September 30, 2026, as compared to Rs 42.78 crore for the same quarter in the previous year. Total income increased by 25.45% to Rs 335.29 crore for Q2FY27 as compared to Rs 267.27 crore for the corresponding quarter of the previous year. On a consolidated basis, the company has reported a 65.88% rise in its net profit at Rs 70.15 crore for Q2FY27, as compared to Rs 42.29 crore for the same quarter in the previous year. Total income increased by 25.01% to Rs 341.44 crore for Q2FY27 as compared to Rs 273.13 crore for the corresponding quarter of the previous year. View : Even with the dip, the company trades at a relatively low price-to-earnings (P/E) ratio of 28.6x compared to peers like Dabur (34.3x) and Godrej Consumer (42.7x). This leaves potential room for long-term re-rating if they can manage inflation. The company preserves high operational flexibility by maintaining a perfect Piotroski score of 9, zero debt, and substantial cash reserves. Through Project Aarohan’s direct distribution model, the company secured more than 100,000 retail outlets and 1,100 distribution partners, instantly fueling a 2% to 3% boost in incremental volume growth.

Bajaj consumer reaffirms fy27 growth at 15-19%.

Bajaj Consumer Care Limited